Torrent Pharmaceuticals Q1 FY27 profit rises to ₹566 crore as revenue jumps 55%

Torrent Pharmaceuticals reported Q1 FY27 net profit of ₹566 crore and a 55% YoY revenue increase to ₹4,921 crore, signaling strong generics momentum in India and emerging markets. However, profit before tax was broadly flat and EPS declined year-on-year, while expenses rose sharply and exceptional items included acquisition-related fees, inventory write-offs, and restructuring costs. Overall market read-through is limited, with impact largely stock-specific.